Trehalose

Trehalose

SCHEMBL19555099

CC(C)CC(N)C(=O)O.OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC7A5 Q01650 1/20 0.50
▸ CD209 Q9NNX6 1/20 0.49
▸ IGF2R P11717 1/20 0.44
▸ MAPT P10636 1/20 0.42
▸ PTPN1 P18031 2/20 0.42
▸ SLC1A3 P43003 1/20 0.41
▸ SLC1A2 P43004 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ KDR P35968 1/20 0.40
▸ PRKD3 O94806 1/20 0.40
▸ PRKCG P05129 1/20 0.40
▸ PRKCB P05771 1/20 0.40
▸ PRKCA P17252 1/20 0.40
▸ PRKCH P24723 1/20 0.40
▸ PRKCI P41743 1/20 0.40
▸ PRKCE Q02156 1/20 0.40
▸ PRKCQ Q04759 1/20 0.40
▸ PRKCZ Q05513 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trehalose SCHEMBL23716930 0.92 CD209 (0.44) SLC7A5CD209IGF2RMAPTPTPN1
Maltose SCHEMBL8141523 0.89 CD209 (0.51) SLC7A5CD209IGF2RMEN1KMT2A
SCHEMBL19555100 0.86 CD209 (0.46) CD209IGF2RPTPN1MEN1KMT2A
Trehalose SCHEMBL9450109 0.86 CD209 (0.46) CD209IGF2RMAPTPTPN1L3MBTL1
SCHEMBL28329274 0.81 HDAC3 (0.42) CD209MAPTL3MBTL1PRKD3PRKCG
Trehalose SCHEMBL20897335 0.80 CD209 (0.42) CD209IGF2RMAPTPTPN1
Trehalose SCHEMBL15510921 0.80 KMT2A (0.51) CD209IGF2RMAPTPTPN1MEN1
Trehalose SCHEMBL4636635 0.77 IGF2R (0.56) IGF2RMAPTPTPN1L3MBTL1MEN1
SCHEMBL23590699 0.77 L3MBTL1 (0.47) MAPTPTPN1L3MBTL1MEN1KMT2A
SCHEMBL30852788 0.77 CD209 (0.47) CD209IGF2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3452170-A1 DRY POWDER TREPROSTINIL FOR THE TREATMENT OF PULMONARY HYPERTENSION Liquidia Technologies, Inc. (US) 2019-03-13 — — EP disclosed
WO-2017192993-A1 DRY POWDER TREPROSTINIL FOR THE TREATMENT OF PULMONARY HYPERTENSION LIQUIDIA TECHNOLOGIES, INC. (US) 2017-11-09 — — WO disclosed
Send feedback